ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Houlihan Lokey Expands Healthcare Group With Two Senior Hires

Dudley Baker and Kerr Robertson Join as Managing Directors to Cover Healthcare Information Technology and Behavioral and Other Healthcare Services, Respectively

Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, announced today that both Dudley Baker and Kerr Robertson have joined the firm’s Healthcare Group as Managing Directors. Mr. Baker is based in Dallas covering healthcare information technology (HCIT), while Mr. Robertson is based in Charlotte, covering behavioral healthcare and other healthcare services.

Mr. Baker joins the firm after spending eight years with Canaccord Genuity Group. Most recently, he served as a Managing Director and Head of Digital & Tech-Enabled Health Investment Banking for Canaccord Genuity. Prior to joining Canaccord Genuity, Mr. Baker spent almost five years at Avondale Partners, where he led coverage of HCIT. Mr. Baker will partner with Luiz Greca in the HCIT practice to bring best-in-class insights, relationships, and experience to our HCIT clients.

Mr. Robertson comes to Houlihan Lokey from William Blair, where he was a Partner and Managing Director for healthcare investment banking, covering healthcare services focused on behavioral health, post-acute/home health, healthcare staffing, radiology/imaging, and specialty pharmacies. Prior to joining William Blair, he spent 15 years at Wells Fargo Securities.

“I am excited to have both Dudley and Kerr joining our team,” said Mark Francis, Managing Director and Global Head of Healthcare at Houlihan Lokey. “Both of them bring significant experience and insights into two fast-growing healthcare sectors that will enhance our leadership in healthcare services and HCIT. Their expertise and client focus will be a great value for our clients as we continue to grow our market-leading Healthcare Group.”

These appointments follow the addition of Jay Ferguson, who joined the Healthcare Group in Charlotte in September as a Director to further bolster the Group’s coverage of the pharma services sector.

“Dudley and Kerr both exemplify Houlihan Lokey’s team-oriented and deeply client-centric culture,” added Mike Pisani, Co-Head of U.S. Healthcare. “These additions, along with Jay joining earlier this year, place us in a better position than ever to deliver outstanding service to our HCIT and healthcare clients around the world,” he added.

Houlihan Lokey’s Healthcare Group is among the largest of its kind in investment banking, with around 100 financial professionals in New York, Dallas, Los Angeles, Chicago, San Francisco, Atlanta, Minneapolis, Charlotte, Tokyo, Milan, Gurugram, Zurich, and London.

About Houlihan Lokey

Houlihan Lokey, Inc. (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and financial and valuation advisory. Houlihan Lokey serves corporations, institutions, and governments worldwide with offices in the Americas, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. The firm is the No. 1 investment bank for global M&A transactions under $1 billion, the No. 1 M&A advisor for the past eight consecutive years in the U.S., the No. 1 global restructuring advisor for the past nine consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 25 years, all based on number of transactions and according to data provided by Refinitiv.

Contacts

Investor Relations

+1 212.331.8225

IR@HL.com

Media Relations

John Gallagher

+1 917.331.1580

PR@HL.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.